Whyte⁎, M. P., Greenberg, C. R., Kishnani, P., Madson, K., Mhanni, A., Weber, T. J., … Landy, H. (2012). Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults. In Bone (Vol. 50, pp. S39–S39). Elsevier BV. https://doi.org/10.1016/j.bone.2012.02.101

Whyte⁎, M. P., C. R. Greenberg, P. Kishnani, K. Madson, A. Mhanni, T. J. Weber, K. Mack, et al. “Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults.” In Bone, 50:S39–S39. Elsevier BV, 2012. https://doi.org/10.1016/j.bone.2012.02.101.

Whyte⁎ MP, Greenberg CR, Kishnani P, Madson K, Mhanni A, Weber TJ, et al. Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults. In: Bone. Elsevier BV; 2012. p. S39–S39.

Whyte⁎, M. P., et al. “Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults.” Bone, vol. 50, Elsevier BV, 2012, pp. S39–S39. Crossref, doi:10.1016/j.bone.2012.02.101.

Whyte⁎ MP, Greenberg CR, Kishnani P, Madson K, Mhanni A, Weber TJ, Mack K, Reeves A, Plotkin H, Kreher NC, Landy H. Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults. Bone. Elsevier BV; 2012. p. S39–S39.